Marcel Soesan

Upfront Genotyping of <i>DPYD</i>*<i>2A</i> to Individualize Fluoropyrimidine Therapy: A Safety and Cost Analysis

Maarten J. Deenen, Didier Meulendijks, Annemieke Cats et al. · Journal of Clinical Oncology · 2015 · 345 citations · Full text

Medicine, Oncology, Pharmacology +17

Symptomatic venous thromboembolism in cancer patients treated with chemotherapy: an underestimated phenomenon.

Hans‐Martin Otten, Joost Mathijssen, Hugo Ten Cate et al. · PubMed · 2004 · 248 citations

Medicine, Oncology, Surgery +13

Pharmacogenetic Screening of CYP3A and ABCB1 in Relation to Population Pharmacokinetics of Docetaxel

Tessa M. Bosch, Alwin D. R. Huitema, Valerie D. Doodeman et al. · Clinical Cancer Research · 2006 · 125 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Pretreatment serum uracil concentration as a predictor of severe and fatal fluoropyrimidine-associated toxicity

Didier Meulendijks, Linda M. Henricks, Bart Jacobs et al. · British Journal of Cancer · 2017 · 122 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Magnesium Levels in Critically Ill Patients

Henk J. Huijgen, Marcel Soesan, Renata Sanders et al. · American Journal of Clinical Pathology · 2000 · 118 citations

Medicine, Biochemistry, Micronutrient Deficiency +14